Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone
Prostate cancer is the second most frequently diagnosed cancer in the men population. Combination anticancer therapy using doxorubicin (DOX) and another extract of traditional Chinese medicine is one nano-sized drug delivery system promising to generate synergistic anticancer effects, maximize the t...
Saved in:
Main Authors: | Guanxing Sun (Author), Kai Sun (Author), Jie Sun (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer
by: Yang Chen, et al.
Published: (2022) -
Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015) -
Prostate-specific Antigen as a Predictor for the Diagnosis of Prostate Adenocarcinoma
by: Wilfredo Valiente Morejón, et al.
Published: (2015) -
Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy
by: Dongdong Bi, et al.
Published: (2018) -
Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer
by: Rien Ritawidya, et al.
Published: (2023)